Pluri Inc. Prepaid Expense, Current
Pluri Inc. (PLUR) had Prepaid Expense, Current of $235.00 thousand as of 2025-06-30, per its 10-K filed 2025-09-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2025-09-17
- 2025-06-30: Prepaid Expense, Current $235.00K.
- 2024-06-30: Prepaid Expense, Current $222.00K.
- 2023-06-30: Prepaid Expense, Current $442.00K.
- 2022-06-30: Prepaid Expense, Current $403.00K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2025-06-30 | $235.00K 10-K · filed 2025-09-17 |
| 2024-06-30 | $222.00K 10-K · filed 2025-09-17 |
| 2023-06-30 | $442.00K 10-K · filed 2024-09-18 |
| 2022-06-30 | $403.00K 10-K · filed 2023-09-12 |
| 2021-06-30 | $333.00K 10-K · filed 2022-09-21 |
| 2020-06-30 | $445.00K 10-K · filed 2021-09-13 |
| 2019-06-30 | $532.00K 10-K · filed 2020-09-10 |
| 2018-06-30 | $602.00K 10-K · filed 2019-09-12 |
| 2017-06-30 | $882.00K 10-K · filed 2018-09-12 |
| 2016-06-30 | $300.00K 10-K · filed 2017-09-07 |
| 2015-06-30 | $919.00K 10-K · filed 2016-09-07 |
| 2014-06-30 | $382.00K 10-K · filed 2015-09-09 |
| 2012-06-30 | $45.00K 10-K · filed 2012-09-10 |
| 2012-03-31 | $172.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $217.00K 10-Q · filed 2012-02-09 |
| 2011-09-30 | $334.00K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $314.00K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |